Barclays’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
45,810
+21,409
| +88% | +$628K | ﹤0.01% | 2473 |
|
|
2025
Q1 | $627K | Sell |
24,401
-5,656
| -19% | -$145K | ﹤0.01% | 2709 |
|
|
2024
Q4 | $867K | Buy |
30,057
+13,594
| +83% | +$392K | ﹤0.01% | 2715 |
|
|
2024
Q3 | $391K | Buy |
16,463
+12,051
| +273% | +$286K | ﹤0.01% | 3128 |
|
|
2024
Q2 | $76K | Sell |
4,412
-2,151
| -33% | -$37.1K | ﹤0.01% | 3505 |
|
|
2024
Q1 | $147K | Sell |
6,563
-5,216
| -44% | -$117K | ﹤0.01% | 3487 |
|
|
2023
Q4 | $216K | Buy |
11,779
+6,917
| +142% | +$127K | ﹤0.01% | 3471 |
|
|
2023
Q3 | $85K | Buy |
4,862
+4,057
| +504% | +$70.9K | ﹤0.01% | 3388 |
|
|
2023
Q2 | $15K | Sell |
805
-2,525
| -76% | -$47.1K | ﹤0.01% | 4014 |
|
|
2023
Q1 | $57K | Buy |
+3,330
| New | +$57K | ﹤0.01% | 3755 |
|
|
2022
Q2 | – | Sell |
-1,254
| Closed | -$44K | – | 4953 |
|
|
2022
Q1 | $44K | Buy |
+1,254
| New | +$44K | ﹤0.01% | 4052 |
|